Preventive drugs' value for money disputed

Many widely prescribed drugs for disease prevention lack valid evidence that they are cost effective and more should be done to assess real-world effectiveness, researchers have argued.

Writing in a BMJ editorial, Finnish researchers argued that efficacy data derived from clinical trials of preventive drugs such as statins and bisphosphonates are not valid evidence of good value for money in reality.

They claimed that benefits seen in carefully controlled trials may not apply in practice. Factors such as age, sex, provider compliance, patient adherence and diagnosis accuracy can all vary in reality.

‘This gap between the ideal and clinical circumstances raises the question of how well our most widely used preventive drugs work in real life,’ they said.

To illustrate the point, authors examined the effectiveness of bisphosphonates in Finland, basing outcomes on entry criteria relevant to clinical trials of the drug.

They estimated that treating all 1.86m citizens aged 50 years and over would prevent only 343 fractures.

‘Thus, although there are claims that important preventive drugs such as statins, antihypertensives, and bisphosphonates are cost effective, there are no valid data on the effectiveness, and particularly the cost effectiveness, in usual clinical care.’

The Finnish researchers said governments and drug approval bodies should promote and fund cost effectiveness trials, and they called for true comparative effectiveness research to become routine.

‘Unless this is done, the important question whether preventive pharmacotherapy is cost effective will remain unanswered.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

NHS app will not meet July rollout deadline, NHS England confirms

NHS app will not meet July rollout deadline, NHS England confirms

The NHS app will not be fully functional in every GP practice in England by the 'ambitious'...

MIMS Learning Live now bigger than ever

MIMS Learning Live now bigger than ever

It is now less than two weeks until MIMS Learning Live: South opens its doors to...

GMC sets out expectations for doctors' reflective practice

GMC sets out expectations for doctors' reflective practice

The GMC has joined forces with eight other healthcare regulators to highlight the...

Babylon GP at Hand opens doors to NHS patients in second major city

Babylon GP at Hand opens doors to NHS patients in second major city

Babylon GP at Hand has begun recruiting NHS patients in Birmingham, in a move that...

Setting up our PCN has been hard work, but I'm positive about the future

Setting up our PCN has been hard work, but I'm positive about the future

As primary care networks (PCNs) prepare to go live on 1 July, network clinical director...

GPs reduce work over pension taxes that cost '£2 for every £1 earned'

GPs reduce work over pension taxes that cost '£2 for every £1 earned'

Four in 10 primary care doctors have reduced their workload or considered doing so...